

Cover Story
Free
The American Society of Clinical Oncology has reached a deal that will allow two companies—Tempus and Precision Health AI—to curate and license the data in CancerLinQ, the professional society's venture into Big Data.
In Brief


Clinical Roundup
Drugs & Targets


Trending Stories
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”
- The other side of the patient portal: Reflections from a cancer center leader
- Surviving cancer is often not a patient’s most challenging battle
- Unlocking the future of precision medicine:
The untapped power of RNA